Subcutaneous electrode and lead with temporary pharmacological agents
First Claim
1. An implantable lead system, comprising:
- a lead comprising a lead body;
an electrode coupled to the lead body, the electrode configured for subcutaneous non-intrathoracic placement within a patient; and
a pharmacological agent provided on the lead, the pharmacological agent providing a temporary therapeutic treatment to subcutaneous non-intrathoracic tissue.
1 Assignment
0 Petitions
Accused Products
Abstract
An implantable subcutaneous device and method employ a lead and an electrode for cardiac monitoring and intervention. The device includes an implantable lead having a lead body, a subcutaneous electrode coupled to the lead body, and a pharmacological agent provided on the implantable lead and/or electrode. The pharmacological agent provides a temporary therapeutic treatment to subcutaneous non-intrathoracic tissue. A method of implanting subcutaneous leads involves providing a lead including a lead body, a subcutaneous electrode, and a pharmacological agent, and delivering the pharmacological agent to subcutaneous non-intrathoracic tissue surrounding the lead.
189 Citations
107 Claims
-
1. An implantable lead system, comprising:
-
a lead comprising a lead body;
an electrode coupled to the lead body, the electrode configured for subcutaneous non-intrathoracic placement within a patient; and
a pharmacological agent provided on the lead, the pharmacological agent providing a temporary therapeutic treatment to subcutaneous non-intrathoracic tissue. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9)
-
-
10. An implantable system, comprising:
-
a can;
a lead comprising a lead body, the lead body extending from the can;
an electrode coupled to the lead body, the electrode configured for subcutaneous non-intrathoracic placement within a patient; and
a pharmacological agent provided on the implantable system, the pharmacological agent providing a temporary therapeutic treatment to subcutaneous non-intrathoracic tissue. - View Dependent Claims (11, 12, 13, 14, 15, 16, 17, 18)
-
-
19. An implantable lead, comprising:
-
a lead body;
an electrode coupled to the lead body, the electrode configured for subcutaneous non-intrathoracic placement within a patient; and
a pharmacological agent provided on the electrode, the pharmacological agent providing a temporary therapeutic treatment to subcutaneous non-intrathoracic tissue. - View Dependent Claims (20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31)
-
-
32. An implantable lead, comprising:
-
a lead body;
an electrode assembly coupled to the lead body, the electrode assembly configured for subcutaneous non-intrathoracic placement within a patient; and
a plurality of pharmacological agents provided on the electrode assembly, the pharmacological agents providing a plurality of temporary therapeutic treatments to subcutaneous non-intrathoracic tissue. - View Dependent Claims (33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54)
-
-
55. A method of lead implantation, comprising:
-
delivering into subcutaneous non-intrathoracic tissue a lead comprising a lead body, an electrode, and a pharmacological agent on the electrode; and
delivering the pharmacological agent from the electrode to subcutaneous non-intrathoracic tissue substantially surrounding the electrode. - View Dependent Claims (56, 57, 58, 59, 60)
-
-
61. An implantable lead, comprising:
-
a lead body;
an electrode coupled to the lead body, the electrode configured for subcutaneous non-intrathoracic placement in a patient; and
means for delivering a pharmacological agent to subcutaneous non-intrathoracic tissue substantially surrounding the electrode. - View Dependent Claims (62, 63, 64, 65, 66, 67)
-
-
68. An implantable system, comprising:
-
a can;
a lead comprising a lead body and provided with the can;
an electrode coupled to the lead body, the electrode configured for subcutaneous non-intrathoracic placement within a patient; and
a pharmacological agent provided on the can, the pharmacological agent providing a temporary therapeutic treatment to subcutaneous non-intrathoracic tissue. - View Dependent Claims (69, 70, 71, 72, 73, 74, 75, 76, 77, 78)
-
-
79. An implantable lead, comprising:
-
a lead body;
a plurality of pharmacological agents provided on the lead body, the pharmacological agents providing a plurality of temporary therapeutic treatments to subcutaneous non-intrathoracic tissue; and
an electrode coupled to the lead body, the electrode configured for subcutaneous non-intrathoracic placement within a patient, wherein a first pharmacological agent is provided on at least a portion of the electrode. - View Dependent Claims (80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94)
-
-
95. An implantable system, comprising:
-
a can;
a lead provided with the can, the lead including a lead body and an electrode coupled to the lead body, the electrode configured for subcutaneous non-intrathoracic placement within a patient;
a first pharmacological agent provided on the lead, the first pharmacological agent providing a temporary therapeutic treatment to subcutaneous non-intrathoracic tissue; and
a second pharmacological agent provided on the can, the second pharmacological agent providing a temporary therapeutic treatment to subcutaneous non-intrathoracic tissue. - View Dependent Claims (96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107)
-
Specification